Acupuncture treatment in irritable bowel syndrome

Gut

Volumn 55, Issue 5, 2006, Pages 649-654

  Schneider, A ^a   Enck, P ^b   Streitberger, K ^a   Weiland, C ^a   Bagheri, S ^a   Witte, S ^c   Friederich, H C ^a   Herzog, W ^a   Zipfel, S ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ACUPUNCTURE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; FEMALE; HUMAN; IRRITABLE COLON; MALE; NEEDLE; PAIN; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SLEEP; TREATMENT DURATION;

ACUPUNCTURE THERAPY; ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; NEEDLES; PLACEBOS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 33646252276     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.074518     Document Type: Article

References (54)

1. Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262-8.
2. NIH Consensus Conference. Acupuncture. JAMA 1998;280:1518-24.
3. Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med 2002;136:374-83.
4. Han JS. Acupuncture and endorphins. Neurosci Lett 2004;361:258-61.
5. Hui KK, Liu J, Makris N, et al. Acupuncture modulates the limbic system and subcortical gray structures of the human brain: evidence from fMRI studies in normal subjects. Hum Brain Mapp 2000;9:13-25.
6. Ouyang H, Chen JD. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004;20:831-41.
7. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112:2120-37.
8. Quartero AO, Meineche-Schmidt V, Muris J, et al. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005;(2):CD003460.
9. Spanier JA, Howden CW, Jones MP. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med 2003;163:265-74.
10. Sung JJ. Acupuncture for gastrointestinal disorders: myth or magic. Gut 2002;51:617-19.
11. Chan J, Carr I, Mayberry JF. The role of acupuncture in the treatment of irritable bowel syndrome: a pilot study. Hepatogastroenterology 1997;44:1328-30.
12. Fireman Z, Segal A, Kopelman Y, et al. Acupuncture treatment for irritable bowel syndrome. A double-blind controlled study. Digestion 2001;64:100-3.
13. Lowe C, Depew WT, Vanner SJ. A placebo-controlled, double-blind trial of acupuncture in the treatment of irritable bowel syndrome. Gastroenterology 2000;2000:A3168.
14. Jin HO, Zhou L, Lee KY, et al. Inhibition of acid secretion by electrical acupuncture is mediated via beta-endorphin and somatostatin. Am J Physiol 1996;271:G524-30.
15. Li P, Rowshan K, Crisostomo M, et al. Effect of electroacupuncture on pressor reflex during gastric distension. Am J Physiol Regul Integr Comp Physiol 2002;283:R1335-45.
16. Li Y, Tougas G, Chiverton SG, et al. The effect of acupuncture on gastrointestinal function and disorders. Am J Gastroenterol 1992;87:1372-81.
17. Lux G, Hagel J, Backer P, et al. Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects. Gut 1994;35:1026-9.
18. Rohrbock RB, Hammer J, Vogelsang H, et al. Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: a study in health and IBS. Am J Gastroenterol 2004;99:1990-7.
19. Enck P, Klosterhalfen S. The placebo response in functional bowel disorders: Perspectives and putative mechanisms. Neurogastroenterol Motil 2005;17:325-31.
20. Patel SM, Stason WB, Legedza A, et al. The placebo effects in irritable bowel syndrome (IBS) trials - A meta-analysis. Neurogastroenterol Motil 2005;17:332-40.
21. Welge JA, Keck PE Jr. Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression. Psychopharmacology (Berl) 2003;166:1-10.
22. Moayyedi P. Meta-analysis: Can we mix apples and oranges? Am J Gastroenterol 2004;99:2297-301.
23. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998;352:364-5.
24. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):II43-7.
25. Talley NJ, Holtmann G, Agreus L, et al. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol 2000;95:1439-47.
26. Lowe B, Spitzer RL, Grafe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004;78:131-40.
27. Cheng Xinnong. Chinese acupuncture and moxibustion. Beijing: Foreign Language Press, 1987.
28. Maciocia G. The foundations of Chinese medicine. London: Churchill Livingstone, 1989.
29. Kleinhenz J, Streitberger K, Windeler J, et al. Randomised clinical trial comparing the effects of acupuncture and a newly designed placebo needle in rotator cuff tendinitis. Pain 1999;83:235-41.
30. Streitberger K, Diefenbacher M, Bauer A, et al. Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: A randomised placebo-controlled patient and observer blind trial. Anaesthesia 2004;59:142-9.
31. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527-33.
32. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
33. Radoschewski M, Bellach BM. The SF-36 in the Federal Health Survey - possibilities and requirements for application at the population level. Gesundheitswesen 1999;61:S191-9.
34. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 1999;55:1286-90.
35. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
36. van Dulmen AM, Fennis JF, Bleijenberg G. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. Psychosom Med 1996;58:508-14.
37. Li CK, Nauck M, Loser C, et al. Acupuncture to alleviate pain during colonoscopy. Dtsch Med Wochenschr 1991;116:367-70.
38. Cahn AM, Carayon P, Hill C, et al. Acupuncture in gastroscopy. Lancet 1978;1:182-3.
39. Streitberger K, Friedrich-Rust M, Bardenheuer H, et al. Effect of acupuncture compared with placebo-acupuncture at p6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial. Clin Cancer Res 2003;9:2538-44.
40. White P, Lewith G, Hopwood V, et al. The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial. Pain 2003;106:401-9.
41. McCarney RW, Brinkhaus B, Lasserson TJ, et al. Acupuncture for chronic asthma. Cochrane Database Syst Rev 2004;(1):CD000008.
42. Patel M, Gutzwiller F, Paccaud F, et al. A meta-analysis of acupuncture for chronic pain. Int J Epidemiol 1989;18:900-6.
43. Linde K, Streng A, Jürgens S, et al. Acupuncture for patients with migraine. JAMA 2005;293:2118-25.
44. Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 2005;330:1202-5.
45. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
46. Posserud I, Agerforz P, Ekman R, et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004;53:1102-8.
47. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 1999;107:91-7S.
48. de Craen AJ, Moerman DE, Heisterkamp SH, et al. Placebo effect in the treatment of duodenal ulcer. Br J Clin Pharmacol 1999;48:853-60.
49. Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287:1840-7.
50. Vase L, Robinson ME, Verne GN, et al. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003;105:17-25.
51. Kreitler S, Kreitler H, Carasso R. Cognitive orientation as predictor of pain relief following acupuncture. Pain 1987;28:323-41.
52. De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain 2002;96:393-402.
53. Reynaert C, Janne P, Vause M, et al. Clinical trials of antidepressants: the hidden face: where locus of control appears to play a key role in depression outcome. Psychopharmocology (Berl) 1995;119:449-54.
54. Schneider A, Lowe B, Streitberger K. Perception of bodily sensation as a predictor of treatment response on acupuncture for postoperative nausea and vomiting. J Altern Complem Med 2005;11:119-25.